ORGANIGRAM GLOBAL INC.
For the period ended Dec 31, 2025. Filed Dec 31, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Dec 31, 2025 · Filed Dec 31, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Investing in the Future of Seed-Based Cannabis
Investing in the Future of Seed-Based Cannabis
Ralph Risch, CEO of Phylos, noted: “Organigram saw early that the next phase of cannabis production would be driven by scientifically bred genetics. Their investment allows Phylos to accelerate development of new traits and F1 hybrid seeds, while giving Organigram a meaningful economic advantage as the first to deploy those innovations at commercial scale.”
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.